
North America Antimicrobial Surgical Suture Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis
No. of Pages: 111 | Report Code: BMIRE00031797 | Category: Life Sciences
No. of Pages: 111 | Report Code: BMIRE00031797 | Category: Life Sciences
The North America antimicrobial surgical suture market size is expected to reach US$ 329.52 million by 2031 from US$ 159.64 million in 2023. The market is estimated to record a CAGR of 9.6% from 2024–2031.
The North America antimicrobial surgical sutures market is segmented into the US, Canada, and Mexico. In 2023, the US held the largest share of the market. The increasing focus of market players on manufacturing antimicrobial surgical sutures due to the rise in orthopedic surgeries, plastic surgeries, cardiovascular surgeries, and C-section deliveries drives the antimicrobial surgical sutures market.
North America Antimicrobial Surgical Suture Market Strategic Insights
North America Antimicrobial Surgical Suture Market Segmentation Analysis
Key segments that contributed to the derivation of the antimicrobial surgical suture market analysis are type, raw materials, application, and end user.
According to the American College of Surgeons, ~1–2% of individuals in the world are likely to experience chronic wounds once in their lifetime. Similarly, as per the estimates from the Centers for Disease Control and Prevention (CDC), ~385,000 sharps injuries occur among healthcare workers in the US every year, and the number is likely to reach up to 800,000 injuries within one year. Besides sharp injuries, the number of other types of workplace or occupational injuries is increasing worldwide. According to the International Labor Organization, ~2.3 million people experience work-related injuries every year, affecting their health and quality of life. The soaring burden of chronic wounds eventually propels the demand for advanced wound care management methods to substantially reduce the financial burden from national healthcare systems. Various countries spend significant amounts of money on treating injuries and avoiding associated risks. For instance, in the US, the healthcare system spends over US$ 25 billion on treating wounds and related complications every year. Therefore, with the increasing incidence of chronic wounds, the demand for antimicrobial surgical sutures is also increasing worldwide.
Further, the number of general, cardiovascular, orthopedic, gynecological, and cancer surgeries performed in healthcare settings is increasing tremendously across the world. According to the data published by Atrial Health in 2023, ~300,000 cardiac surgeries are performed in the US every year. Moreover, the growing geriatric population contributes to severe health conditions (e.g., hernia and cataracts) that require surgeries as a primary treatment option. The geriatric population is prone to CVDs, orthopedic disorders, metabolic disorders, and neurological disorders, among others. According to the WHO, the aging population across the world is likely to rise from ~1 billion in 2019 to ~2.1 billion by 2050. Aesthetic surgeries have also become common among people working in the entertainment industry. These surgeries are performed on patients who have accidental or inherent deformities and on those who wish to make their appearance more appealing. Therefore, the surging number of surgeries performed in hospitals or similar healthcare institutions is driving the demand for antimicrobial surgical sutures.
Based on country, the North America antimicrobial surgical suture market comprises the US, Canada, and Mexico. The US held the largest share in 2023.
The US antimicrobial surgical suture market is expected to proliferate owing to the increased production of bakery and confectionery The increasing surgical procedure and the rising spending on cosmetic or plastic surgeries in the US are propelling the market growth. As per the American Society of Plastic Surgeons, in 2018, US$ 16.5 Billion was spent on cosmetic procedures in the US. The Mountain/Pacific region in the US is more famous for cosmetic surgeries. More than 1,500,000 surgical cosmetic operations and more than 5,500,000 nonsurgical procedures were carried out in the US.
Cardiovascular diseases (CVDs) and stroke produce immense health burdens in the US. According to the American College of Cardiology's reports, ~800,000 deaths were noted in the United States. The primary cause of death is coronary heart disease, followed by heart stroke and heart failure. However, deaths due to coronary heart disease have declined over the past decade due to the awareness of advanced medical diagnosis, treatments, medical insurance, and reimbursements. Therefore, the rise in medical therapies has led to an increase in cardiovascular, orthopedics, and cosmetic surgeries. This, in turn, will fuel the need for antimicrobial surgical sutures.
North America Antimicrobial Surgical Suture Market Report Highlights
Report Attribute
Details
Market size in 2023
US$ 159.64 Million
Market Size by 2031
US$ 329.52 Million
Global CAGR (2024 - 2031)
9.6%
Historical Data
2021-2022
Forecast period
2024-2031
Segments Covered
By Type
By Raw Materials
By Application
By End User
Regions and Countries Covered
North America
Market leaders and key company profiles
North America Antimicrobial Surgical Suture Market Company Profiles
Some of the key players operating in the market include Advanced MedTech Solutions Pvt. Ltd.; Cencora, Inc. (AmerisourceBergen Corporation); Healthium Medtech Limited; Internacional Farmacéutica SA; Johnson & Johnson; Meril Life Sciences Pvt Ltd; TI Medical; and Unilene among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.
The following methodology has been followed for the collection and analysis of data presented in this report:
The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.
Business Market Insights’ conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis, and gain valuable insights. These research interviews are designed to:
Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:
The North America Antimicrobial Surgical Suture Market is valued at US$ 159.64 Million in 2023, it is projected to reach US$ 329.52 Million by 2031.
As per our report North America Antimicrobial Surgical Suture Market, the market size is valued at US$ 159.64 Million in 2023, projecting it to reach US$ 329.52 Million by 2031. This translates to a CAGR of approximately 9.6% during the forecast period.
The North America Antimicrobial Surgical Suture Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Antimicrobial Surgical Suture Market report:
The North America Antimicrobial Surgical Suture Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Antimicrobial Surgical Suture Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Antimicrobial Surgical Suture Market value chain can benefit from the information contained in a comprehensive market report.